Loss of Sirtuin 1 (SIRT1) induces NF-κB signaling in cachectic muscles, activating the expression of FOXO and NADPH oxidase 4 (Nox4), which trigger protein degradation pathways in pancreatic cancer. Here, NOX4 is linked to pancreatic neoplasm.